Phacoemulsification cataract surgery
Abstract
Introduction: cataract surgery is the result of many years in the evolution of biomedical techniques and technologies. Phacoemulsification is the choice of most surgeons.
Objective: to describe demographic and clinical-surgical aspects in cataract operated by the phacoemulsification technique.
Methods: a descriptive, longitudinal and prospective investigation was carried out on 56 operated (63 eyes) with a diagnosis of cataract by phacoemulsification in the Ophthalmological Center of Ciego de Ávila between: October/2017-September/2018, which met the inclusion and exclusion criteria. Ophthalmological physical examination was always carried out by the same researcher. Ethical principles were met.
Results: the female sex (53,57 %), the age group from 51 to 60 years (30,36 %) and the primary open angle glaucoma (17,46 %) as antecedent prevailed. Endothelial cell density did not show significant loss (preoperative: 77,78 % and postoperative: 60,32 %). The majority (69,84 %) improved postoperative visual acuity. The sphere varied by a mean (preoperative: -1,01D to postoperative: 0,13D) and the cylinder decreased (-0,88D to -0,75D). There were almost no intraoperative complications (93,65 %) and, among postoperative complications, posterior capsule opacity (25,40 %) was the most frequent.
Conclusions: it predominated in women, in the group between 50 and 59 years old, and primary open-angle glaucoma as an ocular pathological antecedent. Postoperative improvement in corrected visual acuity, permissible changes in the corneal endothelium and refractive values close to emmetropia were achieved. There were almost no complications.Downloads
Published
How to Cite
Issue
Section
License
MediCiego does not apply publication charges. The journal is available in open access without restrictions, in compliance with the international policy on open access to information for the exchange of global knowledge.
The authors will retain their copyright and guarantee the journal the right of first publication of their work. MediCiego is licensed under the Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC 4.0) https://creativecommons.org/licenses/by-nc/4.0/deed.es_ES), so it is allowed to copy, reproduce, distribute, publicly communicate the work and generate derivative works, as long as the original author is cited and acknowledged. However, it is not allowed to use the original work for commercial or lucrative purposes.
Authors must sign a copyright agreement through an affidavit of authorship and originality, before publishing.
The authors authorize the publication of their writings; they retain the copyright, and assign to the journal all the rights protected by the Copyright Law that governs Cuba, and implies the edition to disseminate the work.
Likewise, they may establish additional agreements for the non-exclusive distribution of the version of the work published in the journal (for example, placing it in an institutional repository or publishing it in a book), with the recognition of having been first published in this journal.
Declaration of authorship: download here the Affidavit
